Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08M Buy
467,352
+67,727
+17% +$723K 0.04% 393
2026
Q1
$4.44M Buy
+399,625
New +$5.09M 0.04% 384
2025
Q1
Sell
-10,188
Closed -$129K 1613
2024
Q4
$129K Sell
10,188
-537
-5% -$7.1K ﹤0.01% 1390
2024
Q3
$137K Sell
10,725
-58,267
-84% -$713K ﹤0.01% 1357
2024
Q2
$875K Sell
68,992
-11,550
-14% -$200K 0.02% 639
2024
Q1
$1.83M Buy
80,542
+16,915
+27% +$396K 0.04% 394
2023
Q4
$1.58M Buy
63,627
+8,428
+15% +$164K 0.04% 437
2023
Q3
$944K Buy
+55,199
New +$919K 0.03% 532

Other funds holding PATH

Vident Advisory's PATH Position: Q2 2026 in Review

Vident Advisory increased its UiPath (PATH) stake by 17% in Q2 2026, buying an estimated $723K and bringing the position to 467,352 shares worth $5.08M. The position accounts for 0.04% of the portfolio, ranked #393.

Vident Advisory first reported a position in PATH in Q3 2023 and has held it in 8 quarters since. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Vident Advisory held 467,352 shares of UiPath worth $5.08M as of Q2 2026.
  • Vident Advisory bought 67,727 UiPath shares in Q2 2026, an estimated $723K.
  • UiPath made up 0.04% of Vident Advisory's portfolio in Q2 2026, its #393 holding.
  • Vident Advisory first reported a position in UiPath in Q3 2023 and has held it in 8 quarters since.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.